MULTIPLE MYLEOMA

Clinical trials for MULTIPLE MYLEOMA explained in plain language.

Never miss a new study

Get alerted when new MULTIPLE MYLEOMA trials appear

Sign up with your email to follow new studies for MULTIPLE MYLEOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug aims to shield blood cancer patients from deadly infections

Prevention Recruiting now

This study tests whether a medicine called XEMBIFY, given every two weeks alongside standard care, can reduce serious bacterial infections in adults with certain blood cancers (chronic lymphocytic leukemia, multiple myeloma, or non-Hodgkin lymphoma) who also have low antibody lev…

Matched conditions: MULTIPLE MYLEOMA

Phase: PHASE3 • Sponsor: Grifols Therapeutics LLC • Aim: Prevention

Last updated May 26, 2026 10:35 UTC

MULTIPLE MYLEOMA

Get alerted when new MULTIPLE MYLEOMA trials appear

New drug aims to shield blood cancer patients from deadly infections